The prevalence of Alzheimer’s disease among diabetic patients in Saudi Arabia

References

1. 1.↵
   1. Aranda MP,
   2. Kremer IN,
   3. Hinton L,
   4. Zissimopoulos J,
   5. Whitmer RA,
   6. Hummel CH, et al.

   Impact of dementia: health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc 2021; 69: 1774-1783.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Naguib R,
   2. Soliman ES,
   3. Neimatallah FM,
   4. AlKhudhairy NS,
   5. ALGhamdi AM,
   6. Almosa RS, et al.

   Cognitive impairment among patients with diabetes in Saudi Arabia: a cross-sectional study. MECP 2020; 27.
3. 3.↵
   1. El-Metwally A,
   2. Toivola P,
   3. Al-Rashidi M,
   4. Nooruddin S,
   5. Jawed M,
   6. AlKanhal R, et al.

   Epidemiology of Alzheimer’s disease and dementia in Arab countries: a systematic review. Behav Neurol 2019; 2019: 3935943.

   OpenUrlPubMed
4. 4.↵
   1. Porsteinsson AP,
   2. Isaacson RS,
   3. Knox S,
   4. Sabbagh MN,
   5. Rubino I.

   Diagnosis of early Alzheimer’s disease: clinical practice in 2021. JPAD 2021; 8: 1-16.
5. 5.↵
   1. Antar SA,
   2. Ashour NA,
   3. Sharaky M,
   4. Khattab M,
   5. Ashour NA,
   6. Zaid RT, et al.

   Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 2023; 168: 115734.

   OpenUrlPubMed
6. 6.↵
   Alzheimer’s Association. 2024 Alzheimer’s disease facts and figures. Alzheimer’s & dementia 2024; 20: 3708-3821.

   OpenUrl
7. 7.↵
   1. Tyrovolas S,
   2. Bcheraoui CE,
   3. Alghnam SA,
   4. Alhabib KF,
   5. Almadi MAH,
   6. Al-Raddadi RM, et al.

   The burden of disease in Saudi Arabia 1990-2017: results from the Global Burden of Disease Study 2017. Lancet Planet Health 2020; 4: e195-e208.

   OpenUrl
8. 8.↵
   1. Cao F,
   2. Yang F,
   3. Li J,
   4. Guo W,
   5. Zhang C,
   6. Gao F, et al.

   The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr 2024; 16: 101.

   OpenUrlPubMed
9. 9.↵
   1. Carpenter BD,
   2. Balsis S,
   3. Otilingam PG,
   4. Hanson PK,
   5. Gatz M.

   The Alzheimer’s disease knowledge scale: development and psychometric properties. Gerontologist 2009; 49: 236-247.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Gouda MA.

    Common pitfalls in reporting the use of SPSS software. Med Princ Pract 2015; 24: 300.

    OpenUrlPubMed
11. 11.↵
    1. Sun Y,
    2. Ma C,
    3. Sun H,
    4. Wang H,
    5. Peng W,
    6. Zhou Z, et al.

    Metabolism: a novel shared link between diabetes mellitus and Alzheimer’s disease. J Diabetes Res 2020; 2020: 4981814.

    OpenUrlPubMed
12. 12.↵
    1. Abbondante S,
    2. Baglietto-Vargas D,
    3. Rodriguez-Ortiz CJ,
    4. Estrada-Hernandez T,
    5. Medeiros R,
    6. Laferla FM.

    Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes. Am J Pathol 2014; 184: 819-826.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. El-Gamal F,
    2. Alali AK Sr.,
    3. Mashaabi MH,
    4. Alsaghah AA,
    5. Shukr FA,
    6. Kadri SY.

    Knowledge on Alzheimer’s disease in Saudi Arabia. Cureus 2023; 15: e50188.

    OpenUrlPubMed
14. 14.↵
    1. Castro-Aldrete L,
    2. Moser MV,
    3. Putignano G,
    4. Ferretti MT,
    5. Schumacher Dimech A,
    6. Santuccione Chadha A.

    Sex and gender considerations in Alzheimer’s disease: the Women’s Brain Project contribution. Front Aging Neurosci 2023; 15: 1105620.

    OpenUrlPubMed
15. 15.↵
    1. Hoppitt TJ,
    2. Sackley C,
    3. Wright C.

    Reply to Roberts et al’s response. Age And Ageing 2010; 39: 517.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Vrijsen J,
    2. Abu-Hanna A,
    3. de Rooij SE,
    4. Smidt N.

    Association between dementia parental family history and mid-life modifiable risk factors for dementia: a cross-sectional study using propensity score matching within the Lifelines cohort. BMJ Open 2021; 11: e049918.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Reinke C,
    2. Buchmann N,
    3. Fink A,
    4. Tegeler C,
    5. Demuth I,
    6. Doblhammer G.

    Diabetes duration and the risk of dementia: a cohort study based on German health claims data. Age Ageing 2022; 51: afab231.
18. 18.↵
    1. Huang HL,
    2. Shyu YL,
    3. Hsu WC,
    4. Liao YT,
    5. Huang HL,
    6. Hsieh SH.

    Effectiveness of a health education program for people with dementia and their family caregivers: an intervention by nurse practitioners. Arch Psychiatr Nurs 2024; 50: 147-159.

    OpenUrlPubMed
19. 19.↵
    1. Silva MVF,
    2. Loures CMG,
    3. Alves LCV,
    4. de Souza LC,
    5. Borges KBG,
    6. Carvalho MDG.

    Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 2019; 26: 33.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Algahtani H,
    2. Shirah B,
    3. Alhazmi A,
    4. Alshareef A,
    5. Bajunaid M,
    6. Samman A.

    Perception and attitude of the general population towards Alzheimer’s disease in Jeddah, Saudi Arabia. Acta Neurol Belg 2020; 120: 313-320.

    OpenUrlPubMed
21. 21.↵
    1. Khanassov V,
    2. Rojas-Rozo L,
    3. Sourial R,
    4. Yang XQ,
    5. Vedel I.

    Needs of patients with dementia and their caregivers in primary care: lessons learned from the Alzheimer plan of Quebec. BMC Fam Pract 2021; 22: 186.

    OpenUrlPubMed
22. 22.↵
    1. Black BS,
    2. Johnston D,
    3. Leoutsakos J,
    4. Reuland M,
    5. Kelly J,
    6. Amjad H, et al.

    Unmet needs in community-living persons with dementia are common, often non-medical and related to patient and caregiver characteristics. Int Psychogeriatr 2019; 31: 1643-1654.

    OpenUrlPubMed
23. 23.↵
    1. Alorfi NM.

    Public awareness of Alzheimer’s disease: a cross-sectional study from Saudi Arabia. Int J Gen Med 2022; 15: 7535-7546.

    OpenUrlPubMed
24. 24.↵
    1. Parveen S,
    2. Mehra A,
    3. Kumar K,
    4. Grover S.

    Knowledge and attitude of caregivers of people with dementia. Geriatr Gerontol Int 2022; 22: 19-25.

    OpenUrlPubMed
25. 25.↵
    1. Wang KC,
    2. Woung LC,
    3. Tsai MT,
    4. Liu CC,
    5. Su YH,
    6. Li CY.

    Risk of Alzheimer’s disease in relation to diabetes: a population-based cohort study. Neuroepidemiology 2012; 38: 237-244.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. McCurry SM,
    2. Logsdon RG,
    3. Mead J,
    4. Pike KC,
    5. La Fazia DM,
    6. Stevens L, et al.

    Adopting evidence-based caregiver training programs in the real world: outcomes and lessons learned from the STAR-C Oregon Translation study. J Appl Gerontol 2017; 36: 519-536.

    OpenUrlPubMed